학술논문

Clinical study of Photodynamic Therapy for Head and Neck Cancer
Document Type
Journal Article
Source
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY. 1996, 6(2):111
Subject
Excimer dye laser
Head and neck cancer
Hematoporphyrin derivative
Photodynamic therapy
エキシマ・ダイ・レーザー
ヘマトポルフィリン誘導体
光線力学的療法
頭頸部癌
Language
English
ISSN
1349-581X
1884-474X
Abstract
Photodynamic therapy (PDT) is a recently developed treatment involving the use of a photosensitizer and low power light, usually from a laser, to selectively destroy tumor cells. At present, we perform PDT for head and neck cancer using excimer dye lasers with hematoporphyrin derivative as a photosensitizer. This study attempted to assess the utility and safety of PDT and to investigate the long-term outcome. All 24 patients had squamous cell carcinoma : 15 with laryngeal, 5 with lingual or oral, and 4 with pharyngeal cancer and were treated by PDT. Data were obtained from records from February 1988 through April 1995. Following PDT, 12 of 15 laryngeal cases were classified as complete remissin (CR ), as were 3 of the 5 lingual or oral, and one of the 4 pharyngeal cancer patients. The longest duration of CR in cases treated by PDT alone was 89 months. Photosensitivity was experienced by all patients, but required no treatment. Liver, kidneys and bone marrow showed no abnormal values. There were no clinically relevant adverse reactions and patients with severe complications due to other types of treatment and elderly patients were also treated safely with this therapy.